Literature DB >> 29426767

Full-thickness rectal biopsy in children suspicious for Hirschsprung's disease is safe and yields a low number of insufficient biopsies.

Niels Bjørn1, Lars Rasmussen2, Niels Qvist2, Sönke Detlefsen3, Mark Bremholm Ellebæk2.   

Abstract

INTRODUCTION: The diagnosis of Hirschsprung's disease (HD) relies on the histological demonstration of aganglionosis in the bowel wall. Biopsies may be obtained by rectal suction biopsy (RSB) or by transanal full-thickness excision biopsy (FTB). The objective of the present study was to evaluate the frequency of complications and inconclusive biopsies after FTB in children referred with suspicion of HD. The secondary objective was to calculate the frequency of proven aganglionosis.
METHODS: A retrospective chart review was performed of all patients under the age of 16years who underwent transanal FTB during the time period of 2008-2014.
RESULTS: A total of 555 patients were included in the review. Inconclusive biopsies were found at the primary biopsy in 35 patients (5.9%). Aganglionosis was found in 12% of the cases. The complication rate was 6.6% (39 patients), 85% of which were classified as a Clavien-Dindo I-II and 15% were classified as Clavien-Dindo III.
CONCLUSIONS: In this retrospective evaluation of FTB for the diagnosis of HD, the frequency of inconclusive biopsies at primary attempt was low and the complication rate was relatively high. However, most were minor complications. LEVEL OF EVIDENCE: III.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aganglionosis; Biopsy; Complications; Full thickness; Hirschsprung's disease; Inconclusive

Mesh:

Year:  2018        PMID: 29426767     DOI: 10.1016/j.jpedsurg.2018.01.005

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Current practice of rectal biopsies for the diagnosis of Hirschsprung's disease in Latin America: an international online survey.

Authors:  Maricarmen Olivos; Catalina Correa; Luis De la Torre
Journal:  Pediatr Surg Int       Date:  2021-01-12       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.